have recently defined RGB zones for cannula step placement in the putamen to improve delivery efficiency within that target, while limiting the spread of the therapeutic agent into regions outside the target. 17 In the course of multiple MR imaging studies we have observed significant regional differences in the factors governing the flow of interstitially infused substances within the CNS. 9 In the present study, we have extended this methodology to the thalamus and brainstem of nonhuman primates to define optimal cannula placement parameters for CED. The thalamus, by virtue of its extensive cortical projections, 8 is likely to become an important target for the treatment of diseases with a strong cortical component. Similarly, the brainstem, often a problematic region for surgical intervention, represents an important target for therapeutic strategies in such diseases as certain lysosomal storage disorders, traumatic brain injury, and brain tumors. Standardization of CED parameters in these important brain regions is likely to aid in the translation of novel therapies that depend upon direct delivery to parenchyma.
Methods

Experimental Animals
Six normal adult nonhuman primates, including 4 cynomolgus monkeys (2 male, 2 female; age range 7-8 years, mean age 8.2 years, weight range 5-12.8 kg) and 2 rhesus macaques (1 male, age 10 years, weight 12.2 kg; 1 female, age 8 years, weight 6 kg) were included in the study. Experiments were performed according to the NIH guidelines under protocols approved by the Institutional Animal Care and Use Committee at the University of California, San Francisco, and at Valley Biosystems (Sacramento, California). These animals received a total of 22 intracranial infusions of gadoteridol (2 mM) into the thalamus and brainstem. Infusions were performed according to previously established CED techniques for nonhuman primates. 1 
Infusion Procedure
All primates underwent baseline MR imaging prior to surgery to visualize anatomical landmarks and to generate stereotactic coordinates of the proposed infusion target sites. Nonhuman primates underwent stereotactic placement of the MR imaging-compatible plastic guide cannula array for CED into the thalamus and brainstem. The guide cannula array was 12 mm in diameter and 14 mm in height, and contained 27 access holes. Each guide cannula array was secured to the skull with plastic screws and dental acrylic. After placement of this array, animals recovered for at least 2 weeks before initiation of infusion procedures. On the day of infusion, animals were anesthetized with isoflurane (Aerrane, Ohmeda Pharmaceutical Products Division). The head of each animal was then placed in an MR imaging-compatible stereotactic frame, and baseline MR imaging was performed. Vital signs, such as pulse and partial pressure of oxygen, were monitored throughout the procedure.
Briefly, the infusion system consisted of a fused silica reflux-resistant cannula 5, 9 that was connected to a loading line (containing gadoteridol), an infusion line with oil, and another infusion line with trypan blue solution. A 1-ml syringe (filled with trypan blue solution) mounted onto a Harvard MR imaging-compatible infusion pump (Harvard Bioscience Company) regulated the flow of fluid through the delivery cannula. Based on MR imaging coordinates, the cannula was inserted into the targeted region of the brain through the previously placed guide cannula array. The length of each infusion cannula was measured to ensure that the distal tip extended 3 mm beyond the cannula step. This created a stepped design that was proximal to the tip of the cannula, maximizing fluid convection during CED while minimizing reflux along the cannula tract. In the text, we refer to this transition from fused silica tip to a fused silica sheath as the "step," and all positioning data are derived from the position of this step due to its unambiguous visibility on MR imaging.
We maintained positive pressure in the infusion cannula during its insertion into the brain to minimize possible tip occlusion during cannula insertion. After securing placement of the infusion cannula, the CED procedures were initiated at the same time as acquisition of MR imaging data in real time (real-time convective delivery). Throughout the study, we used the same infusion parameters for every nonhuman primate that was infused. Infusion rates were as follows: 0.1 μl/minute was applied when lowering the cannula to the targeted area (to prevent tissue from entering the tip), and upon achieving the target, increased at 10-minute intervals to 0.2, 0.5, 0.8, 1.0, and 2.0 μl/minute. Approximately 15 minutes after infusion, the cannula was withdrawn from the brain. Four animals received multiple infusions. Each animal experienced at least a 4-week interval between each infusion procedure.
Magnetic Resonance Imaging
Nonhuman primates were sedated with a mixture of 7 mg/kg intramuscular ketamine and 3 mg/kg intramuscular xylazine. After sedation, each animal was placed in an MR imaging-compatible stereotactic frame. The ear-bar and eye-bar measurements were recorded, and an intravenous line was established. Magnetic resonance imaging data were then obtained, after which animals were allowed to recover under close observation until able to right themselves in their home cages. Magnetic resonance images of the brain in 14 CED in 4 nonhuman primates were acquired on a 1.5-T Siemens Magnetom Avanto system (Siemens AG). Three-dimensional rapid gradient echo images were obtained using the following parameters: TR 2110 msec, TE 3.6 msec, flip angle 15°, number of excitations = 1 (repeated 3 times), 240 × 240 matrix, FOV 240 × 240 × 240 pixels, 1-mm slice thickness. These parameters resulted in a 1-mm 3 voxel volume. The scanning time was approximately 9 minutes.
Magnetic resonance images of 8 CED in 2 nonhuman primates were acquired on a 1.5-T Sigma LX scanner (GE Medical Systems) with a 5-inch surface coil on the subject's head, parallel to the floor. Spoiled gradient echo images were T1-weighted and obtained with a spoiled gradient recalled acquisition in steady-state sequence: TR 2170 msec, TE 3. 
Volume and Distance Measurements in Nonhuman Primate Brain
Magnetic resonance images, obtained from each realtime convective delivery, were used to measure the distance from the cannula step to the midline (step-midline), to the cannula entry point (step-entry) in the target region (thalamus or brainstem), and to the lateral borders (steplateral) of the target regions. The measurements were made on an Apple Macintosh G4 computer with OsiriX Medical Image Software (version 2.5.1). OsiriX software reads all data specifications from digital imaging and communications in medicine (DICOM) formatted MR images obtained via a local PACS. The distances from the cannula step to each of the points mentioned above were manually defined and then calculated by the software after each point was selected. All distances were measured in the same manner on all MR imaging sections.
The x, y, and z coordinate values of each cannula step location in the green zone (> 98% thalamic containment of the tracer) were determined by 2D orthogonal MR images generated by OsiriX software, in which MR images were projected in all 3 planes (axial, coronal, and sagittal). We used the midpoint of the AC-PC line, the MCP, as the zero point (0,0,0) in 3D brain space. Briefly, the AC-PC line was drawn on the midsagittal plane, and the MCP was defined. Orthogonal horizontal (axial) and vertical (coronal) planes through the MCP were then determined, with the axial plane containing the AC-PC line, along with the midsagittal plane. The x, y, and z values of the cannula step were then obtained by measurements of the distance from the cannula step to the midline on the coronal MR imaging plane (x value), the distance anterior (or posterior) to the MCP on the axial MR imaging plane (y value), and the distance above (or below) the AC-PC line on the sagittal MR imaging (z value). All the distances were measured (in millimeters) in the same manner on MR imaging sections for each case.
Magnetic resonance images were also used for volumetric quantification (Vd) of the distribution of gadoteridol. The Vd of gadoteridol in the brain of each subject was also quantified on an Apple Macintosh G4 computer. Regions of interest were manually defined by outlining the enhancing area of infusion in the thalamus or brainstem, and in surrounding structures. The OsiriX software then calculated the area from each MR image and established the volume of the ROI, based on the areas defined multiplied by slice thickness (PACS volume). The boundaries of each distribution were defined in the same manner in the series of MR imaging sections. The sum of the PACS ROI volumes (number of MR imaging slices evaluated) for the particular distribution undergoing analysis determined the measured volume. The defined ROI volumes allowed for 3D image reconstruction using BrainLAB software.
Statistical Analysis
The distribution of gadoteridol and the distance variables (cannula step to midline; cannula step to region entry point; and cannula step to lateral border of each region) were compared across subject groups using the Student ttest. The criterion for statistical significance for all tests was a p value < 0.05.
Results
In this study, 6 nonhuman primates received 22 infusions, 14 in the thalamus and 8 in brainstem. Real-time convective delivery images of nonhuman primate brains were obtained to evaluate the distribution of gadoteridol and to determine the variable measures in each target structure. Magnetic resonance images were used to measure the distance from the cannula step to the midline (step-midline), to cannula entry point (step-entry) in the target region (thalamus or brainstem), and to the lateral borders (steplateral) of the target regions. In the thalamus, 8 infusions were contained completely within the target region (excellent containment), with no leakage (Table 1) . Six infusions resulted in good containment of gadoteridol tracer within the thalamus, with slight leakage into adjacent white matter tracts and/or the lenticular fasciculus. All infusions into the brainstem resulted in excellent containment of the tracer within the target, with very slight leakage into adjacent structures observed in only 1 case (Table 2) .
When the percentage of infused tracer contained within the thalamus was plotted against each measured variable, it became apparent that the distance from the cannula step to the entry point or lateral border of the thalamus correlated with the pattern of distribution of infusate into the thalamus (Fig. 1A and B) . In 8 infusions in which thalamic containment exceeded 95% (range 98.2-100%; mean 99.7 ± 0.2%), the step-entry ranged from 2.8 to 5.8 mm (mean 4.0 ± 0.3 mm), the step-lateral ranged from 2.2 to 7.0 mm (mean 3.6 ± 0.6 mm), and the step-midline ranged from 5.0 to 7.7 mm (mean 6.2 ± 0.4 mm; Table 1 ). The distance from the cannula step to the Step to EP (mm)
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Step to ML (mm) midline (Fig. 1C ) correlated poorly with thalamic containment. We defined the spatial limits associated with near-total quantitative thalamic containment of the tracer (> 98%) as the "green zone." A corresponding "blue zone" was defined as 67 to 93% (mean 85 ± 3.8%) thalamic containment of the tracer, which occurred in the remaining 6 thalamic infusions. These values were indicative of a small amount of leakage into the surrounding structures, with leakage into white matter tracts in 3 cases, lenticular fasciculus in 2 cases, and both white matter tract and lenticular fasciculus in 1 case. The step-entry ranged from 1.3 to 2.2 mm (mean 1.8 ± 0.2 mm) in 4 cases with leakage into white matter tract, the step-lateral ranged from 1.3 mm to 1.9 mm (mean 1.7 ± 0.2 mm) in 3 cases with leakage into the lenticular fasciculus, and the step-midline ranged from 5.9 to 10.1 mm (mean 7.6 ± 0.6 mm). The red zone could not be defined because there were no cases in which the tracer was poorly confined to the thalamus in this study.
Similarly, a green zone for cannula placement in the brainstem was also defined from 8 separate infusions. Containment within the brainstem was 100% in 7 cases and 95% in 1 case. The step-entry ranged from 3.6 to 12.6 mm (mean 7.3 ± 1.0 mm), the step-lateral ranged from 2.9 to 5.1 mm (mean 4.1 ± 0.3 mm), and the step-midline ranged from 1.6 to 3.9 mm (mean 2.6 ± 0.3 mm). When the percentage of infused tracer contained within the brainstem was plotted against each variable, no correlation was found between distribution of infusate into the brainstem and any variable (Fig. 2) , suggesting that the infusion cannula was placed properly in these cases. Blue and red zones could not be defined because there were no cases in which the tracer was partially or poorly confined to the brainstem in this study.
Volume of Distribution of Gadoteridol in the Thalamus
When the step was placed within the green zone in 8 cases, excellent Vd of gadoteridol was obtained in the thalamus, ranging from 159 to 660 mm 3 (mean 405 ± 67 mm 3
; Fig. 3A and B) . Infusion volume in the thalamus ranged from 74 to 169 μl (mean 121 ± 14 μl) in this study. The Vd/Vi ratio ranged from 3.2 to 4.2 (mean 3.8 ± 0.4). Two cases were found to have minor leakage of gadoteridol into the white matter tract at the end of infusion, and their Vds in the white matter tract were 2.8 and 5.5 mm 3 . The 3D image reconstruction of the Vd in the thalamus is shown in green in Fig. 4 .
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Fig. 1.
Graphs showing the correlations between spatial coordinates and distribution of MR imaging tracer in the thalamus (Th). The MR images were used to measure the distance from the cannula step to the midline (step-midline), to cannula entry point (step-entry) in the target region (thalamus or brainstem), and to the lateral borders (step-lateral) of the target regions. The green points represent data points in the green zone, and the blue points represent data points in the blue zone.
zone, the Vd of gadoteridol in the thalamus ranged from 59 to 268 mm 3 (mean 191 ± 38 mm 3 ; Fig. 3A and B) . Infusion volumes ranged from 20 to 106 μl (mean 69 ± 13 μl). The Vd/Vi ratio ranged from 2.3 to 4.3 (mean 3.3 ± 0.4). All 6 cases were found to have leakage into the white matter tract, and the final Vd in the white matter tract ranged from 8.3 to 44 mm 3 (mean 24 ± 7 mm ). Representative MR imaging shown in Fig. 3 depicts a green zone (Fig. 3D-F) and a blue zone (Fig. 3H-J) infusion.
Volume of Distribution of Gadoteridol in the Brainstem
All 8 brainstem infusions were placed in the green zone, resulting in excellent distribution of gadoteridol volumes, ranging from 224 to 886 mm 3 (mean 585 ± 75 mm 3 ; Fig. 5A and B) . Infusion volume in the brainstem ranged from 60 to 212 μl (mean 158 ± 21 μl). The Vd/ Vi ratio ranged from 2.5 to 5.6 (mean 3.9 ± 0.4). Gadoteridol was distributed rostrally toward the midbrain and caudally toward the medulla oblongata. No distribution of gadoteridol into the cerebellum was observed. In 1 case, a small amount of leakage of gadoteridol (31 mm 3 ) into the thalamus was observed at the end of the infusion. Representative MR images demonstrating brainstem real-time convective delivery is shown in Fig. 5C-F . The 3D image reconstruction of Vd in the brainstem is depicted in red in Fig. 4 .
Coordinates for the Green Zone in the Thalamus and Brainstem
The MCP was defined as the zero point (0,0,0) of a 3D brain space. Based on the MR imaging-derived coordinate measurements for the cannula step, the mean coordinates for placing the step in the thalamic green zone were x = 6.9 ± 0.7 mm lateral (range 4.1-10.2 mm), y = 1.2 ± 0.2 mm posterior (range 0.4 to 1.9 mm), and z = 3.1 ± 0.4 mm superior (range 1.4-4.7 mm). The mean coordinates for the green zone in the brainstem were x = 2.3 ± 0.2 mm lateral (range 1.6-3.5 mm), y = 4.0 ± 0.5 posterior (range 2.6-6.0 mm), and z = 8.9 ± 1.0 mm inferior (range 4.8-11.9 mm).
Optimal Zones for Cannula Step Placement
On the basis of the above analyses, we have defined coordinates for infusions in the thalamus and brainstem that identify preferred cannula step location and optimal distances from different anatomical structures for green and blue zones.
The green zone in the thalamus is defined based on 8 observations as a volume obtained after subtracting 2.8 mm from cannula step to target entry, 5.8 mm from the lower border vertically, 2.2 mm from the lateral border, and 5.0 mm from the midline. The blue zone is defined as a thick shell surrounding the green zone, of which the outer border of the blue zone is approximately 0.5 mm from the outer edge of the green zone. The volume of this green zone is 55.1 mm 3 with an anterior-posterior length of 8.8 mm (Fig. 6 upper) .
The green zone in the brainstem is defined based on 8 observations as a volume obtained after subtracting 3.6 mm from cannula step to target entry, 6.6 mm away from the lower border vertically, 2.9 mm from its lateral border laterally, and ≥ 1.6 mm from midline medially. We outlined the green zone only, and then calculated the volume of the green zone to be 50.7 mm 3 with an anterior-posterior length of 6.3 mm (Fig. 7 upper) .
Discussion
In the present study, we correlated the stereotactic localization of the infusion cannula step within the thalamus and brainstem of nonhuman primates with the efficiency of gadoteridol distribution in these target regions. Clearly, some infusions were associated with excellent containment of tracer within the target region, while others were not. The most important variables determining containment of tracer within the thalamus and brainstem were the distance of the cannula step to the entry point of the target region and the distance of the step to the lateral border of the target. Distance of the step to the midline did not correlate with containment. The definition of stereotactic coordinates for the cannula, and the resulting percentage of tracer distribution within the target region, permitted us to define a green zone in both the thalamus and brainstem. Similarly, a suboptimal blue zone was defined that might still be acceptable in some cases. However, once any leakage occurs, the Vd/Vi ratio in the thalamus is lower. The green zone predicts effective Vd into the thalamus and brainstem, minimizing the risk of untoward leakage of infusate into adjacent white matter tracts. This strategy may be most effective for local treatments to the thalamic region, or to have more complete delivery of substances to the cortex. 8 More precise targeting and infusion into thalamic or brainstem subregions, such as specific nuclei within the thalamus or brainstem, may eventually be considered for therapeutic approaches.
We realize that extrapolation of nonhuman primate data to humans is somewhat uncertain. With that caution in mind, we wanted to illustrate a putative target region in the human thalamus and brainstem. Therefore, we used the parameters for green and blue zones obtained from nonhuman primates to predict corresponding zones in the human thalamus and brainstem. We also outlined the green zone on serial human MR images, and then calculated the area from each MR image to predict the volume of human green zones with values obtained in nonhuman primates, to subtract regions in which the cannula step should not reside. In the human thalamus, a target locus of 734.5 mm 3 is suggested with an anteriorposterior distance of 22 mm ( Fig. 6 lower) ; similarly, a human brainstem locus of 2219.4 mm 3 is suggested with an anterior-posterior distance of 20 mm (Fig. 7 lower) . Corresponding zones in the nonhuman primate and human are compared in Figs. 8 and 9 on the same scale. Our computational analysis suggested that the human brain has a proportionately larger green zone compared with nonhuman primates, and that the 13-and 44-fold differences in the volume of the green zone in the thalamus (Figs. 6 and 8 ) and brainstem (Figs. 7 and 9) , respectively, are due to the differences in spherical volumetric geometry between nonhuman primates and humans, as shown previously. 18 Apart from the obvious difference in size, the overall morphology of the green zone is similar. This knowledge is critical in providing guidance to the neurosurgeon to obtain excellent Vd of therapeutics in the thalamus and brainstem of patients, without risking significant leakage into surrounding anatomical structures. Additional nonhuman primate studies and real-time convective delivery infusions in human patients will have to be performed to confirm and refine the optimal loci in human thalamus and brainstem. In this study, we have established a method for safely delivering, and effectively distributing, infusate with gadoteridol as an MR imaging tracer within these structures.
With more widespread use of CED in the treatment of human neurological diseases, 4, 6, 10, 13 controlled distribution of novel therapeutic agents such as viral vectors and liposomal drugs within brain structures is essential. It appears important, for optimization of efficacy, to cover the entire targeted treatment volume but to avoid spillover into adjacent regions of the brain or CSF pathways. It has been very challenging to predict the distribution of therapeutics delivered by CED, due to a lack of understanding of optimal cannula placement. This is true for delivery of chemotherapeutic agents to brain tumors, as well as for infusion of growth factors, enzymes, and viral vectors.
2,7,9,15 The limited size of brain structures of nonhu- Fig. 6 . Three-dimensional reconstruction of the green zone, and representative volumes of the green zone, in the nonhuman primate (upper) and human (lower) thalamus, respectively. The area of the green zone was defined from MR images as a volume at least 2.8 mm ventral to the entry point, at least 5.8 mm away from the lower border (2.8 mm from cannula tip to lower border plus 3 mm of tip length) vertically, greater than 2.2 mm from the lateral border laterally, and more than 5 mm from the midline medially. Fig. 7 . Three-dimensional reconstruction of the green zone, and representative volumes of the green zone, in the nonhuman primate (upper) and human (lower) brainstem, respectively. The area of the green zone was defined from MR images as a volume at least 3.6 mm ventral to the entry point, at least 6.6 mm away from the lower border (3.6 mm from cannula tip to lower border plus 3 mm of tip length) vertically, greater than 2.9 mm from the lateral border laterally, and more than 1.6 mm from the midline medially.
man primates restricts infusion volume. As a result, it is easy to exceed the borders of the targeted structure inadvertently. Even in our nonhuman primates, however, realtime convective delivery allows us to adjust CED at any given point, based on real-time observations, to optimize infusion within the target volume. In our study, however, all the infusions in the brainstem led to adequate distribution of infusate, except in 1 case in which a small amount of leakage of gadoteridol into the thalamus was observed at the end of the infusion. Therefore, our data does not provide information regarding poor and suboptimal areas for brainstem infusion. The brainstem is relatively insensitive to cannula placement, in contrast to the thalamus and putamen, because the brainstem is a relatively large anatomical structure in the brain. Our data, therefore, only describe an acceptable locus without fully defining its borders. Nevertheless, this retrospective identification provides a degree of confidence regarding cannula placement in the brainstem for CED.
Conclusions
This study provides quantitative analysis of cannula placement and infusate distribution by real-time MR imaging and defines an optimal zone for infusion in the nonhuman primate thalamus and brainstem. Moreover, real-time visualization of cannula placement by MR imaging, and subsequent precise control of the extent of infusate distribution, addresses an important safety issue, especially when parenchymal infusion of large volumes is necessary and leakage or excessive distribution may be undesirable. Cannula placement recommendations developed from such translational nonhuman primate studies have significant implications for the design of anticipated clinical trials, featuring CED therapy into the thalamus and brainstem for CNS diseases such as enzyme deficiencies, stroke, and traumatic brain injury. Real-time convective delivery infusions in human patients will need to be carefully monitored to confirm and refine the extrapolated green zone in the thalamus and brainstem of the human brain based on data from nonhuman primates, thereby establishing reliable guidelines for neurosurgical infusions of therapeutic agents in clinical practice. 
